These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 36059045)

  • 21. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
    Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
    Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunomodulatory amnion-derived mesenchymal stromal cells preserve muscle function in a mouse model of Duchenne muscular dystrophy.
    Nitahara-Kasahara Y; Nakayama S; Kimura K; Yamaguchi S; Kakiuchi Y; Nito C; Hayashi M; Nakaishi T; Ueda Y; Okada T
    Stem Cell Res Ther; 2023 Apr; 14(1):108. PubMed ID: 37106393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice.
    Boulanger Piette A; Hamoudi D; Marcadet L; Kyomi Labelle F; Ovidiu David R; Bossé S; Argaw A; Frenette J
    PLoS One; 2018; 13(6):e0198408. PubMed ID: 29879154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postdevelopmental knockout of Orai1 improves muscle pathology in a mouse model of Duchenne muscular dystrophy.
    García-Castañeda M; Michelucci A; Zhao N; Malik S; Dirksen RT
    J Gen Physiol; 2022 Sep; 154(9):. PubMed ID: 35939054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemojuvelin is a novel suppressor for Duchenne muscular dystrophy and age-related muscle wasting.
    Zhang P; He J; Wang F; Gong J; Wang L; Wu Q; Li W; Liu H; Wang J; Zhang K; Li M; Huang X; Pu C; Li Y; Jiang F; Wang F; Min J; Chen X
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):557-573. PubMed ID: 30884219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.
    van Putten M; Kumar D; Hulsker M; Hoogaars WM; Plomp JJ; van Opstal A; van Iterson M; Admiraal P; van Ommen GJ; 't Hoen PA; Aartsma-Rus A
    Neuromuscul Disord; 2012 May; 22(5):406-17. PubMed ID: 22284942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways.
    Sadler KJ; Gatta PAD; Naim T; Wallace MA; Lee A; Zaw T; Lindsay A; Chung RS; Bello L; Pegoraro E; Lamon S; Lynch GS; Russell AP
    Exp Physiol; 2021 Jul; 106(7):1597-1611. PubMed ID: 33963617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipocalin 2 Influences Bone and Muscle Phenotype in the
    Ponzetti M; Ucci A; Maurizi A; Giacchi L; Teti A; Rucci N
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy.
    Wehling-Henricks M; Sokolow S; Lee JJ; Myung KH; Villalta SA; Tidball JG
    Hum Mol Genet; 2008 Aug; 17(15):2280-92. PubMed ID: 18430716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibiting the inflammasome with MCC950 counteracts muscle pyroptosis and improves Duchenne muscular dystrophy.
    Dubuisson N; Davis-López de Carrizosa MA; Versele R; Selvais CM; Noel L; Van den Bergh PYD; Brichard SM; Abou-Samra M
    Front Immunol; 2022; 13():1049076. PubMed ID: 36569900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.
    Morales MG; Gutierrez J; Cabello-Verrugio C; Cabrera D; Lipson KE; Goldschmeding R; Brandan E
    Hum Mol Genet; 2013 Dec; 22(24):4938-51. PubMed ID: 23904456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted expression of heme oxygenase-1 in satellite cells improves skeletal muscle pathology in dystrophic mice.
    Florczyk-Soluch U; Polak K; Jelinkova S; Bronisz-Budzyńska I; Sabo R; Bolisetty S; Agarwal A; Werner E; Józkowicz A; Stępniewski J; Szade K; Dulak J
    Skelet Muscle; 2024 Jun; 14(1):13. PubMed ID: 38867250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RhoA/ROCK signalling activated by ARHGEF3 promotes muscle weakness via autophagy in dystrophic mdx mice.
    You JS; Kim Y; Lee S; Bashir R; Chen J
    J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1880-1893. PubMed ID: 37311604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy.
    Wasala NB; Bostick B; Yue Y; Duan D
    Hum Mol Genet; 2013 Jul; 22(13):2634-41. PubMed ID: 23459935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy.
    Abou-Samra M; Selvais CM; Boursereau R; Lecompte S; Noel L; Brichard SM
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):518-533. PubMed ID: 31965757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy.
    Hammers DW; Hart CC; Matheny MK; Wright LA; Armellini M; Barton ER; Sweeney HL
    Sci Rep; 2020 Aug; 10(1):14070. PubMed ID: 32826942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice.
    Jin Q; Qiao C; Li J; Xiao B; Li J; Xiao X
    Skelet Muscle; 2019 May; 9(1):16. PubMed ID: 31133057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In dystrophic
    Debruin D; McRae NL; Addinsall AB; McCulloch DR; Barker RG; Debrincat D; Hayes A; Murphy RM; Stupka N
    Am J Physiol Cell Physiol; 2024 Oct; 327(4):C1035-C1050. PubMed ID: 39159389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression profiling in exercised mdx suggests a role for extracellular proteins in the dystrophic muscle immune response.
    Coles CA; Gordon L; Hunt LC; Webster T; Piers AT; Kintakas C; Woodman K; Touslon SL; Smythe GM; White JD; Lamandé SR
    Hum Mol Genet; 2020 Feb; 29(3):353-368. PubMed ID: 31696230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TIPE2 gene transfer with adeno-associated virus 9 ameliorates dystrophic pathology in mdx mice.
    Gao S; Lu A; Amra S; Guo P; Huard J
    Hum Mol Genet; 2019 May; 28(10):1608-1619. PubMed ID: 30608588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.